Flávia Martins

Flávia Martins

Auto-generated profile, based on publicly available information

Flávia Martins

Instituto de Investigação e Inovação em Saúde (I3S), Rua Alfredo Allen 208, 4200-135 Porto, Portugal

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in Cancers
Verified
Journal Article
Open access
PDF file
PCPatrícia Dias Carvalho
Patrícia Dias Carvalho
AMAna Luísa Machado
Ana Luísa Machado
FMFlávia Martins
Flávia Martins
Raquel SerucaRaquel Seruca
Raquel Seruca
Sérgia VelhoSérgia Velho
Sérgia Velho
Current evidence strongly suggests that cancer cells depend on the microenvironment in order to thrive. In fact, signals from the surrounding tumor microenvironment are crucial for cancer cells´ aggressiveness, altering their expression profile and favoring their metastatic potential. As such, targeting the tumor microenvironment to impair cancer progression became an attractive therapeutic option. Interestingly, it has been shown that oncogenic KRAS signaling promotes a pro-tumorigenic microenvironment, and the associated crosstalk alters the expression profile of cancer cells. These findings award KRAS a key role in controlling the interactions between cancer cells and the microenvironment, granting cancer a poor prognosis. Given the lack of effective approaches to target KRAS itself or its downstream effectors in the clinic, exploring such interactions may open new perspectives on possible therapeutic strategies to hinder mutant KRAS tumors. This review highlights those communications and their implications for the development of effective therapies or to provide insights regarding response to existing regimens.

5 March 2020
Verified
Book Chapter
Closed access
PDF file
NMNuno Miguel Mendes
Nuno Miguel Mendes
PCPatrícia Dias Carvalho
Patrícia Dias Carvalho
FMF. Martins
F. Martins
SMS. Mendonça
S. Mendonça
AMA. R. Malheiro
A. R. Malheiro
Sérgia VelhoSérgia Velho
Sérgia Velho

28 March 2020 in Cancers
Verified
Journal Article
Open access
PDF file
FMFlávia Martins
Flávia Martins
RORosa Oliveira
Rosa Oliveira
BCBruno Cavadas
Bruno Cavadas
FPFilipe Pinto
Filipe Pinto
ACAna Patrícia Cardoso
Ana Patrícia Cardoso
ACAngela Costa
Angela Costa
In colon cancer, the prognostic value of macrophages is controversial, and it is still unknown how hypoxia modulates macrophage–cancer cell crosstalk. To unravel this, co-cultures of human primary macrophages and colon cancer cells were performed at 20% and 1% O2, followed by characterization of both cellular components. Different colon cancer patient cohorts were analyzed for hypoxia and immune markers, and their association with patient overall survival was established. A positive correlation between HIF1A and CD68 in colon cancer patients was identified but, unexpectedly, in cases with higher macrophage infiltration, HIF1A expression was associated with a better prognosis, in contrast to breast, gastric, and lung cancers. Under hypoxia, co-cultures’ secretome indicated a shift towards a pro-inflammatory phenotype. These alterations occurred along with increased macrophage phagocytic activity and decreased SIRPα expression. Cancer cells were more invasive and exhibited higher CD47 expression. We hypothesize that the better prognosis associated with HIF1AHighCD68High tumors could occur due to macrophagic pro-inflammatory pressure. Indeed, we found that tumors HIF1AHighCD68High expressed increased levels of CD8A, which is positively correlated with HIF1A. In conclusion, we show that in colon cancer, hypoxia drives macrophages into a pro-inflammatory phenotype, concomitant with increased infiltration of anti-tumor immune cells, favoring better disease outcome.

24 September 2018 in Journal of Water and Health
Verified
Journal Article
Open access
PDF file
ABAna Barbosa-Vasconcelos
Ana Barbosa-Vasconcelos
ÂMÂngelo Joel Ferreira Mendes
Ângelo Joel Ferreira Mendes
FMFlávia Martins
Flávia Martins
ELElisabete Lopes
Elisabete Lopes
AMAna Machado
Ana Machado
Lucinda J. BessaLucinda J. Bessa
Lucinda J. Bessa
The Ave River in northern Portugal has a history of riverbanks and water quality degradation. The river water quality was assessed by physicochemical, biological (macroinvertebrates) and microbiological (Enterococcus spp. and Escherichia coli) parameters in six locations (A–F, point A being the nearest to the source) throughout its course during a year. Epilithic biofilms were studied through PCR-DGGE. Antimicrobial susceptibility testing helped selecting isolates (n = 149 E. coli and n = 86 enterococci) for further genetic characterization. Pursuant to physicochemical and macroinvertebrates-based parameters, the river water was of reasonable quality according to European legislation (Directive 2000/60/EC). However, the microbiological analysis showed increased fecal contamination downstream from point C. At point D, four carbapenem-resistant E. coli isolates were recovered. Paradoxically, point D was classified as a point of Good Water Quality according to macroinvertebrates results. Point F presented the highest contamination level and incidence of multidrug-resistant (MDR) isolates in the water column (13 MDR enterococci out of 39 and 33 MDR E. coli out of 97). Epilithic biofilms showed higher diversity in pristine points (A and B). Thus, biological and microbiological parameters used to assess the water quality led to divergent results; an outcome that reinforces the need for a holistic evaluation.

11 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
PCPatrícia Dias Carvalho
Patrícia Dias Carvalho
SMSusana Mendonça
Susana Mendonça
FMFlávia Martins
Flávia Martins
Maria  OliveiraMaria Oliveira
Maria Oliveira
Sérgia VelhoSérgia Velho
Sérgia Velho
KRAS mutations have been shown to extend their oncogenic effects beyond the cancer cell, influencing the tumor microenvironment. Herein, we studied the impact of mutant KRAS on the modulation of the pro-tumorigenic properties of cancer-associated fibroblasts (CAFs), including α-SMA expression, TGFβ1 and HGF production, extracellular matrix components and metalloproteinases expression as well as collagen contraction and migration capacities. To do so, CCD-18Co normal-like colon fibroblasts were challenged with conditioned media from control and KRAS silenced colorectal cancer (CRC) cells. Our results showed that the mutant KRAS CRC cell-secreted factors were capable of turning normal-like fibroblasts into CAF-like by modulating the α-SMA expression, TGFβ1 and HGF production and migration capacity. Oncogenic KRAS played a secondary role as its silencing did not completely impair the capacity of CRC cells to modulate most of the fibroblast properties analyzed. In summary, our work suggests that mutant KRAS does not play a major role in controlling the CRC cell-secreted factors that modulate the behavior of fibroblasts. The fact that CRC cells retain the capacity to modulate the pro-tumorigenic features of fibroblasts independently of KRAS silencing is likely to negatively impact their response to KRAS inhibitors, thus standing as a putative mechanism of resistance to KRAS inhibition with potential therapeutical relevance.

21 June 2022 in Cells
Verified
Journal Article
Open access
PDF file
PCPatrícia Dias Carvalho
Patrícia Dias Carvalho
FMFlávia Martins
Flávia Martins
JCJoana Carvalho
Joana Carvalho
Maria  OliveiraMaria Oliveira
Maria Oliveira
Sérgia VelhoSérgia Velho
Sérgia Velho
Understanding how mutant KRAS signaling is modulated by exogenous stimuli is of utmost importance to elucidate resistance mechanisms underlying pathway inhibition failure, and to uncover novel therapeutic targets for mutant KRAS patients. Hence, aiming at perceiving KRAS-autonomous versus -non autonomous mechanisms, we studied the response of two mutant KRAS colorectal cancer cell lines (HCT116 and LS174T) upon KRAS silencing and treatment with rhTGFβ1-activated fibroblasts secretome. A proteomic analysis revealed that rhTGFβ1-activated fibroblast-secreted factors triggered cell line-specific proteome alterations and that mutant KRAS governs 43% and 38% of these alterations in HCT116 and LS174T cells, respectively. These KRAS-dependent proteins were localized and displayed molecular functions that were common to both cell lines (e.g., extracellular exosome, RNA binding functions). Moreover, 67% and 78% of the KRAS-associated proteome of HCT116 and LS174T cells, respectively, was controlled in a KRAS-non-autonomous manner, being dependent on fibroblast-secreted factors. In HCT116 cells, KRAS-non-autonomously controlled proteins were mainly involved in proteoglycans in cancer, p53, and Rap1 signaling pathways; whereas in LS174T cells, they were associated with substrate adhesion-dependent cell-spreading and involved in metabolic processes. This work highlights the context-dependency of KRAS-associated signaling and reinforces the importance of integrating the tumor microenvironment in the study of KRAS-associated effects.